Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is a leading pharmaceutical company based in China, specializing in the development and sale of products for allergic diseases diagnosis and treatment. With a diverse product portfolio that includes dust mites drops and skin prick diagnosis kits, the company has an ESG score of 25.7, indicating a medium risk assessment.